Keyphrases
Ovarian Cancer
86%
Confidence Interval
83%
Denmark
66%
High-risk Human Papillomavirus (HR-HPV)
64%
Ovarian Cancer Risk
50%
Epithelial Ovarian Cancer
49%
Odds Ratio
34%
National Cohort Study
29%
Human Papillomavirus Vaccine
25%
Hazard Ratio
24%
Cervical Cancer
24%
Cancer Association
23%
Risk Factors
21%
Ovarian Cancer Patients
18%
Papillomavirus Infections
17%
Meta-analysis
15%
Cervical Cancer Screening
14%
HPV16
14%
Human Papillomavirus Types
13%
Human Papillomavirus Testing
13%
Borderline Tumor
13%
Systematic Meta-analysis
13%
Histological Subtypes
12%
Genital Warts
12%
Pooled Analysis
12%
Breast Cancer
12%
Population-based Cohort Study
12%
Quadrivalent Human Papillomavirus Vaccine
12%
Endometrial Cancer
11%
Fertility Drugs
11%
Human Papillomavirus Prevalence
10%
Cancer Study
10%
Incidence Rate
10%
Single nucleotide Polymorphism
9%
Cancer Cases
9%
Borderline Ovarian Tumor
9%
Ovarian Tumor
9%
Sexual Behavior
9%
Vaccination
9%
Population-based Study
8%
Prognostic Value
8%
Cancer Risk
8%
SNP
8%
Standardized Incidence Ratio
7%
Young Women
7%
Endometriosis
7%
Ovarian Cancer Survival
7%
Polymorphism
7%
Vulvar Cancer
7%
Genome-wide Association Study
7%
Medicine and Dentistry
Ovarian Cancer
100%
Wart Virus
85%
Cohort Analysis
52%
Malignant Neoplasm
46%
Krukenberg Tumor
45%
Neoplasm
34%
Odds Ratio
27%
Cervical Cancer
25%
Cancer Risk
25%
Hazard Ratio
24%
Ovarian Tumor
22%
Prevalence
21%
Case-Control Study
21%
Papillomavirus Infection
18%
Disease
18%
Single Nucleotide Polymorphism
15%
Cervical Intraepithelial Neoplasia
15%
Breast Cancer
15%
Wart Virus Vaccine
15%
Genital Wart
14%
Cervical Cancer Screening
14%
Endometrial Cancer
12%
Human Papillomavirus Type 16
12%
Pooled Analysis
11%
Infection
11%
Precancerous Condition
11%
Squamous Cell Carcinoma
10%
Systematic Review
9%
Childbirth
9%
Meta-Analysis
9%
Hormone Therapy
9%
Human Papillomavirus Type 6
9%
Population
8%
Proportional Hazards Model
8%
Cytotechnology
8%
Human Immunodeficiency Virus
7%
Standardized Incidence Ratio
7%
Logistic Regression Analysis
7%
Serous Carcinoma
7%
Cancer Incidence
7%
Cancer Susceptibility
7%
Endometriosis
7%
Genome Wide Association Study
7%
Prostate Cancer
6%
Assisted Reproductive Technology
6%
Human Papillomavirus Type 18
6%
Lifespan
6%
Anal Cancer
6%
Vulvar Cancer
6%
P16
5%